Bharat Biotech Enrols Over 25,000 Volunteers For Covaxin Phase 3 Trial | Read

PUBLISHED ON: January 7, 2021 | Duration: 2 min, 22 sec

facebooktwitteremailkoo
loading..
Bharat Biotech has enrolled 25,800 volunteers for phase 3 clinical trials of its COVID-19 vaccine, the company said today. The maker of Covaxin is one of the two firms cleared by the government to deploy their product for mass inoculation in the country. The other is Oxford-AstraZeneca's Covishield manufactured by the Serum Institute of India.
ALSO WATCH
WHO Says 'The End Is In Sight' For Covid Pandemic 

Just Added Videos

................................ Advertisement ................................

Short videosBy Firework

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com